n.a. (SHP)

0.00
NYSE
Prev Close 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.00
Exchange NYSE
Div & Yield N.A. (N.A)

Latest News

Shire And Kamada Announce FDA Approval Of Expanded Label For Self-infusion Of GLASSIA For The Treatment Of Emphysema Due To Severe AAT Deficiency

Shire And Kamada Announce FDA Approval Of Expanded Label For Self-infusion Of GLASSIA For The Treatment Of Emphysema Due To Severe AAT Deficiency

GLASSIA [Alpha-1 Proteinase Inhibitor (Human)] is the only FDA approved alpha-1 antitrypsin (AAT) augmentation treatment that patients can self-infuse at home

Baxalta Shareholders Vote To Approve Combination

Baxalta Shareholders Vote To Approve Combination

Baxalta Incorporated (NYSE:BXLT) today announced the results of a vote on the proposals identified in the definitive proxy statement/prospectus, dated April 18, 2016, at a special meeting of shareholders held earlier this...

Shire To Present New Research At 2016 American Psychiatric Association Annual Meeting

Shire To Present New Research At 2016 American Psychiatric Association Annual Meeting

Reinforces Long-Standing Commitment to Furthering Knowledge of B.E.D. and ADHD

Shire Submits NDA To FDA For New Formulation Of Vyvanse® (lisdexamfetamine Dimesylate) CII As Chewable Tablets

Shire Submits NDA To FDA For New Formulation Of Vyvanse® (lisdexamfetamine Dimesylate) CII As Chewable Tablets

New formulation, in adherence with approved indications, intended for children, adolescents and adults with difficulty swallowing or opening capsules